Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma

Table 1

Gene normalized levels of SLC6A14 mRNA.

Patient #	Adjacent normal duct	Adjacent normal acinar	Distant normal acinar	Tumor	Tumor/normal^1
1	2.54			138.68	54.60
2	0.84			36.16	43.05
3	0.17			1.51	8.88
4	1.16			119.89	103.35
5	10.31	0.13		62.44	6.06
6	1.34	0.10		11.82	8.82
7	0.29			7.83	27.00
8	1.10			29.73	27.03
9	6.66	0.37		54.33	8.16
10	0.22			342.69	1557.68
11	0.38	0.13		22.01	57.92
12	2.60			27.22	10.47
13	2.26			11.24	4.97
14	8.94			102.6	11.48
15	0.36			34.56	96.00
16	4.44	0.03		10.00	2.25
17 (CT-iso)			0.03	13.10	436.67
18 (CT-iso)			0.03	22.56	752.00
19 (CT-iso)			0.10	103.03	1030.30
20 (CT-iso)			0.02	439.30	21965.00
21 (CT-iso)			0.04	15.49	387.25

CT-iso, computed tomography-isoattenuating.
Adjacent normal duct was used for the calculation in patients 1–16. Distant normal acinar was used for patients 17–21. Values are in RPKM (mapped reads per kilobase per million mapped reads).